A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
基本信息
- 批准号:07044285
- 负责人:
- 金额:$ 1.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for international Scientific Research
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Serum mannose-binding protein (MBP) is a C-type lectin capable of activating the complement system (the lectin pathway). A novel serine protease designated MASP (MBP-associated-serine protease) is involved in the activation by MBP,exerting C4-and C2-activating capacity when bound to MBP on its ligands.1.We investigated reconstitution of recombinant MBPs and MASP for exhibiting complement activation. Wild type recombinant MBP (MBP_G) was found to be able to be associated with MASP,resulting in complement activation, whereas recombinant mutated MBP (MBP_D) in which glycine (G) is substituted with asparatic acid (D) in the fifth collagen repeat and responsible for the complement-dependent opsonic defect is unable to activate complement when incubated with MASP.These results indicate that lack of complement-activating capacity of MBP_D might be due to inability of association with MASP (Biochem.J., 1995).2.To clarify the mechanisms by which C1r/C1s is substitute for MASP in the activation of the lectin pathway, we measured the affinity constant of C1r/C1s or C1q and MBP using a Biacore apparatus. The results indicate that affinity constants of the four possible mixtures are very similar. Since only MBP-MASP and C1q-C1r/C1s complexes were present in serum, the other factors would influence the interaction of MBP and C1r/C1s.3.To evaluate the role of the MASP in various diseases, we established sandwich ELISA using several monoclonal antibodies. The mean value of normal human is about 6mug/ml. Estimation of MASP in various diseases is currently under investigation.
血清甘露糖结合蛋白(MBP)是能够激活补体系统(凝集素途径)的C型凝集素。一种新型的丝氨酸蛋白酶指定的MASP(MBP相关链蛋白酶)参与MBP的激活,当与MBP绑定到MBP的配体上时施加C4和C2激活能力。补体激活。发现野生型重组MBP(MBP_G)能够与MASP相关联,导致补体激活,而重组突变的MBP(MBP_D),其中甘氨酸(g)在第五次胶原重复和第五次胶原重复和高素质的重复酸(D)中代替与MASP一起孵育时,负责补体依赖性Opsonic缺陷无法激活补体。这些结果表明,MBP_D的补体激活能力的缺乏可能是由于与MASP无关(Biochem.j。,1995年).2。为了阐明在凝集素途径激活中C1R/C1s代替MASP的机制,我们使用Biacore设备测量了C1R/C1S或C1Q和MBP的亲和力常数。结果表明,这四种可能的混合物的亲和力常数非常相似。由于血清中仅存在MBP-MASP和C1Q-C1R/C1S络合物,因此其他因素将影响MBP和C1R/C1S.3.3.为了评估MASP在各种疾病中的作用,我们使用几个夹心ELISA建立单克隆抗体。正常人的平均值约为6mug/ml。目前正在研究各种疾病中MASP的估计。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Matsushita, R.A.B.Ezekowitz: "The Gly54*Asp allecic form of human mannose-binding protein (MBP) tails to bind MBP-associated serine protease" Biochem.J.311. 1021-1023 (1995)
M.Matsushita、R.A.B.Ezekowitz:“人甘露糖结合蛋白 (MBP) 尾部的 Gly54*Asp 等位基因形式可结合 MBP 相关丝氨酸蛋白酶”Biochem.J.311。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Matsushita, T.Fujita: "Cleavage of the third component of complement (C3) by mannose-binding protein-associated serine protease (MASP) with subsequent complement activation" Immunobiol. 194. 443-448 (1995)
M.Matsushita、T.Fujita:“甘露糖结合蛋白相关丝氨酸蛋白酶 (MASP) 裂解补体的第三个成分 (C3),并随后激活补体”Immunobiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Matsushita,R.A.B.Ezekowitz,T.Fujita: "TheGly・54→Aspallelicform of human mannosc-binding protein(MBP)fails to bind MBP-associated serine protease" Biochem.J.311. 1021-1023 (1995)
M.Matsushita、R.A.B.Ezekowitz、T.Fujita:“人甘露糖结合蛋白 (MBP) 的 Gly·54→Aspallelic 形式无法结合 MBP 相关丝氨酸蛋白酶”Biochem.J.311 1021-1023 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Matsushita,T.Fujita: "The lectin pathway of complement activation." Res.Immunol. (in press). (1996)
M.Matsushita,T.Fujita:“补体激活的凝集素途径。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Matsushita,T.Fujita: "Cleavage of the third component of conplement(C3)by mannose-binding protein-associated serine protease(MASP)with subsequent complement activation" Immunobiol.194. 443-448 (1995)
M.Matsushita、T.Fujita:“甘露糖结合蛋白相关丝氨酸蛋白酶 (MASP) 裂解补体的第三个成分 (C3),并随后激活补体”Immunobiol.194。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJITA Teizo其他文献
FUJITA Teizo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJITA Teizo', 18)}}的其他基金
The lectin complement pathway is involved in activation of the alternative pathway
凝集素补体途径参与旁路途径的激活
- 批准号:
21390086 - 财政年份:2009
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of host defense lectin.s in innate immunity
宿主防御凝集素在先天免疫中的作用
- 批准号:
13143204 - 财政年份:2001
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Molecular basis of complement activation by ficolins throu the lectin pathsay
纤维胶蛋白通过凝集素途径激活补体的分子基础
- 批准号:
12470079 - 财政年份:2000
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A NOVEL LECTIN-DEPENDENT ACTIVATION PATHWAY OF COMPLEMENT
一种新型的凝集素依赖性补体激活途径
- 批准号:
06454223 - 财政年份:1994
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
- 批准号:
06044189 - 财政年份:1994
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for international Scientific Research
Production of chimeric protein to scavenge immune complexes
产生嵌合蛋白以清除免疫复合物
- 批准号:
02557026 - 财政年份:1990
- 资助金额:
$ 1.28万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似国自然基金
补体凝集素途径激活导致IgA肾病肾脏微血管病变的机制研究
- 批准号:82170710
- 批准年份:2021
- 资助金额:53 万元
- 项目类别:面上项目
IgA1分子N-糖链诱导凝集素途径补体激活在IgA肾病发病中的作用和机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
C型凝集素样受体CLEC-2通过旁分泌信号途径调控胃癌干细胞niche以及化疗抵抗的功能机制研究
- 批准号:31870800
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
三疣梭子蟹补体凝集素激活途径及其介导的母源免疫机制研究
- 批准号:41776159
- 批准年份:2017
- 资助金额:71.0 万元
- 项目类别:面上项目
LOX-1/Cullin7介导的泛素化修饰在脂肪细胞胰岛素抵抗中的作用及机制研究
- 批准号:81603171
- 批准年份:2016
- 资助金额:17.3 万元
- 项目类别:青年科学基金项目
相似海外基金
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10990669 - 财政年份:2024
- 资助金额:
$ 1.28万 - 项目类别:
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 1.28万 - 项目类别:
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10737359 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
睡眠呼吸暂停加慢性阻塞性肺病(重叠综合征)对心血管的影响
- 批准号:
10733384 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别:
Cell-free hemoglobin-oxidized LDL-LOX-1 axis and microvascular hyperpermeability during sepsis
脓毒症期间无细胞血红蛋白氧化的 LDL-LOX-1 轴和微血管通透性过高
- 批准号:
10739620 - 财政年份:2023
- 资助金额:
$ 1.28万 - 项目类别: